GlassScriptPhysician profile
Whitney L Rintelman
NPI 1982603064
$2,872.86
in general payments reported to CMS, 2019-2025
24 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $739 · 2022: $705 · 2023: $637 · 2024: $542 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.11 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $474.45 | 2021-2024 | Myrbetriq |
| Sumitomo Pharma America, INC. | $411.71 | 2023-2025 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $290.34 | 2021-2022 | |
| Abbvie INC. | $239.21 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $207.37 | 2021-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $181.58 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $176.54 | 2021-2023 | Lynparza |
| Dendreon Pharmaceuticals LLC | $105.70 | 2021-2023 | Provenge |
| Blue Earth Diagnostics | $93.61 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.83 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $90.12 | 2022-2025 | |
| Endo USA, INC. | $80.48 | 2024-2025 | Xiaflex |
| Coloplast Corp | $76.51 | 2023-2025 | Speedicath, Porges Coloplast |
| Myovant Sciences INC. | $74.06 | 2021-2022 | |
| Amgen INC. | $59.81 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $49.90 | 2021-2022 | |
| Boston Scientific Corporation | $38.69 | 2021-2022 | |
| Janssen Biotech, INC. | $24.87 | 2023 | Erleada |
| Tolmar Pharmaceuticals, INC. | $20.34 | 2021 | |
| Progenics Pharmaceuticals, INC. | $19.71 | 2023 | Pylarify |
| Urogen Pharma, INC. | $19.43 | 2023 | Jelmyto |
| Abc Home Medical Supply, INC. | $17.23 | 2023 | |
| Procept Biorobotics Corporation | $15.51 | 2023 | Aquabeam Robotic System |
| Teleflex LLC | $13.86 | 2024 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Rintelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.